ResearcherNational University of SingaporeActive in the last 2 years
Hwee Leong Tan
Matched on ORCID iD 0000-0002-5988-0132; OpenAlex author ID A5046040698. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2025: 3 papers · 2026: 3 papers
Papers 6
- Pancreatic cancer burden across Southeast Asia from 1990 to 2021: An analysis of incidence and mortality based on the global burden of disease study 2021. Co-author DOI 10.1016/j.pan.2025.09.031↗
- Neoadjuvant therapy versus upfront surgery for resectable pancreatic cancer: Updated systematic review, individual-patient-data meta-analysis and trial sequent… Co-author DOI 10.1016/j.surg.2025.109872↗
- Exploring the role of immunotherapy and radiotherapy in the adjuvant landscape of resected pancreatic cancer. Co-author DOI 10.21037/tgh-2026-0026↗
- SEER-based evaluation of lymph node yield as a prognostic indicator of cancer-specific survival in nonmetastatic pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2025.05.008↗
- Clinical Outcomes of Neoadjuvant Therapy Versus Upfront Surgery in Resectable Pancreatic Cancer: Systematic Review and Meta-analysis of Latest Randomized Contr… Co-author DOI 10.1245/s10434-024-16674-y↗
- Surgery and neoadjuvant therapy in locally advanced pancreatic cancer: an umbrella review of survival, resection outcomes, and cost-effectiveness. First author DOI 10.21037/gs-24-421↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ye Xin Koh · 6 shared papers, 2025–2026 · strength 1.88
- Paper Exploring the role of immunotherapy and radiotherapy in the adjuvant landscape of resected pancreatic cancer. DOI 10.21037/tgh-2026-0026↗
- Paper SEER-based evaluation of lymph node yield as a prognostic indicator of cancer-specific survival in nonmetastatic pancre… DOI 10.1016/j.pan.2025.05.008↗
- Paper Surgery and neoadjuvant therapy in locally advanced pancreatic cancer: an umbrella review of survival, resection outcom… DOI 10.21037/gs-24-421↗
- Brian K. P. Goh · 6 shared papers, 2025–2026 · strength 1.88
- Paper Exploring the role of immunotherapy and radiotherapy in the adjuvant landscape of resected pancreatic cancer. DOI 10.21037/tgh-2026-0026↗
- Paper SEER-based evaluation of lymph node yield as a prognostic indicator of cancer-specific survival in nonmetastatic pancre… DOI 10.1016/j.pan.2025.05.008↗
- Paper Surgery and neoadjuvant therapy in locally advanced pancreatic cancer: an umbrella review of survival, resection outcom… DOI 10.21037/gs-24-421↗
- Yun Zhao · 4 shared papers, 2025–2026 · strength 1.12
- Paper SEER-based evaluation of lymph node yield as a prognostic indicator of cancer-specific survival in nonmetastatic pancre… DOI 10.1016/j.pan.2025.05.008↗
- Paper Neoadjuvant therapy versus upfront surgery for resectable pancreatic cancer: Updated systematic review, individual-pati… DOI 10.1016/j.surg.2025.109872↗
- Paper Clinical Outcomes of Neoadjuvant Therapy Versus Upfront Surgery in Resectable Pancreatic Cancer: Systematic Review and … DOI 10.1245/s10434-024-16674-y↗
- Kennedy Yao Yi Ng · 2 shared papers, 2025–2026 · strength 0.55
- Paper Neoadjuvant therapy versus upfront surgery for resectable pancreatic cancer: Updated systematic review, individual-pati… DOI 10.1016/j.surg.2025.109872↗
- Paper Clinical Outcomes of Neoadjuvant Therapy Versus Upfront Surgery in Resectable Pancreatic Cancer: Systematic Review and … DOI 10.1245/s10434-024-16674-y↗
- David Wai-Meng Tai · 2 shared papers, 2025–2026 · strength 0.55
- Paper Neoadjuvant therapy versus upfront surgery for resectable pancreatic cancer: Updated systematic review, individual-pati… DOI 10.1016/j.surg.2025.109872↗
- Paper Clinical Outcomes of Neoadjuvant Therapy Versus Upfront Surgery in Resectable Pancreatic Cancer: Systematic Review and … DOI 10.1245/s10434-024-16674-y↗
- Yun Zhao · 1 shared paper, 2025 · strength 0.33
- Anna Ho Yin Chan · 1 shared paper, 2025 · strength 0.25
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.